Familial Aggregation of Insulin Resistance in First-Degree Relatives of Patients With Nonalcoholic Fatty Liver Disease

Clinical Gastroenterology and Hepatology

Volumn 4, Issue 9, 2006, Pages 1162-1169

  Abdelmalek, Manal F ^a   Liu, Chen ^b   Shuster, Jonathan ^a   Nelson, David R ^a   Asal, Nabih R ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTHRITIS; ARTICLE; BODY MASS; CLINICAL ARTICLE; CLUSTER ANALYSIS; COHORT ANALYSIS; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIABETES MELLITUS; FAMILY HISTORY; FEMALE; GENETIC LINKAGE; GENETIC PREDISPOSITION; HUMAN; HYPERLIPIDEMIA; INSULIN RESISTANCE; LIVER CIRRHOSIS; MALE; NEPHROLITHIASIS; NONALCOHOLIC FATTY LIVER; RELATIVE; RISK; SMOKING;

ADULT; AGED; BODY MASS INDEX; CASE-CONTROL STUDIES; CLUSTER ANALYSIS; FATTY LIVER; FEMALE; HEALTH STATUS; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; PEDIGREE; RISK FACTORS;

EID: 33748126166     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2006.06.001     Document Type: Article

References (61)

1. Lyon H.N., and Hirschhorn J.N. Genetics of common forms of obesity: a brief overview. Am J Clin Nutr 82 Suppl (2005) 215S-217S
2. Rosmond R. Association studies of genetic polymorphisms in central obesity: a critical review. Int J Obes Relat Metab Disord 27 (2003) 1141-1151
3. Lee J.H., Reed D.R., and Price R.A. Leptin resistance is associated with extreme obesity and aggregates in families. Int J Obes Relat Metab Disord 25 (2001) 1471-1473
4. Weijnen C.F., Rich S.S., Meigs J.B., et al. Risk of diabetes in siblings of index cases with type 2 diabetes: implications for genetic studies. Diabet Med 19 (2002) 41-50
5. Froguel P., and Velho G. Genetic determinants of type 2 diabetes. Recent Prog Horm Res 56 (2001) 91-105
6. Haffner S.M., Stern M.P., Hazuda H.P., et al. Increased insulin concentrations in nondiabetic offspring of diabetic patients with insulin resistance. N Engl J Med 319 (1988) 1297-1301
7. Warren J.H., Martin B.C., Krolewshi A.S., et al. Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents. Ann Intern Med 113 (1990) 909-915
8. Sonnenberg G.E., Krakower G.R., Martin L.J., et al. Genetic determinants of obesity-related lipid traits. J Lipid Res 45 (2004) 610-615
9. Roche H.M., Phillips C., and Gibney M.J. The metabolic syndrome: the crossroads of diet and genetics. Proc Nutr Soc 64 (2005) 371-377
10. Martin B.C., Warram J.H., Rosner B., et al. Family clustering of insulin sensitivity. Diabetes 41 (1992) 850-854
11. Marchesini G., Marzocchi R., Agostini F., et al. Nonalcoholic fatty liver disease and the metabolic syndrome. Curr Opin Lipidol 16 (2005) 421-427
12. Bloomgarden Z.T. Second World Congress on the Insulin Resistance Syndrome: insulin resistance syndrome and nonalcoholic fatty liver disease. Diabetes Care 28 (2005) 1518-1523
13. Alberti K.G., Zimmet P., Shaw J., and IDF Epidemiology Task Force Consensus Group. The metabolic syndrome-a new worldwide definition. Lancet 366 (2005) 1059-1062
14. Eckel R.H., Grundy S.M., and Zimmet P.Z. The metabolic syndrome. Lancet 365 (2005) 1415-1428
15. Angelico F., Del Ben M., Conti R., et al. Insulin resistance, the metabolic syndrome, and nonalcoholic fatty liver disease. J Clin Endocrinol Metab 90 (2005) 1578-1582
16. Kim H.J., Kim H.J., Lee K.E., et al. Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults. Arch Intern Med 164 (2004) 2169-2175
17. Bedogni G., Miglioli L., Masutti F., et al. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology 42 (2005) 44-52
18. Poonawala A., Nair S.P., and Thuluvath P.J. Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study. Hepatology 32 (2000) 689-692
19. Adams L.A., Sanderson S., Lindor K.D., et al. The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies. J Hepatol 42 (2005) 132-138
20. Perusse L., Chagnon Y.C., and Bouchard C. Etiology of massive obesity: role of genetic factors. World J Surg 22 (1998) 907-912
21. Rice T., Despres J.P., Daw E.W., et al. Familial resemblance for abdominal visceral fat: the HERITAGE family study. Int J Obes Relat Metab Disord 21 (1997) 1024-1031
22. Lemieux S. Genetic susceptibility to visceral obesity and related clinical implications. Int J Obes Relat Metab Disord 21 (1997) 831-838
23. Park H.S., Yim K.S., and Cho S.I. Gender differences in familial aggregation of obesity-related phenotypes and dietary intake patterns in Korean families. Ann Epidemiol 14 (2004) 486-491
24. Li J.K., Ng M.C., So W.Y., et al. Phenotypic and genetic clustering of diabetes and metabolic syndrome in Chinese families with type 2 diabetes mellitus. Diabetes Metab Res Rev 22 (2006) 46-52
25. Ramachandran A., Snehalatha C., Satyavani K., et al. Cosegregation of obesity with familial aggregation of type 2 diabetes mellitus. Diabetes Obes Metab 2 (2000) 149-154
26. Williams M.A., Qiu C., Dempsey J.C., et al. Familial aggregation of type 2 diabetes and chronic hypertension in women with gestational diabetes mellitus. J Reprod Med 48 (2003) 955-962
27. Elbein S.C. The genetics of human non-insulin-dependent (type 2) diabetes mellitus. J Nutr 127 (1997) 1891S-1896S
28. Willner I.R., Waters B., Patil S.R., et al. Ninety patients with nonalcoholic steatohepatitis: insulin resistance, familial tendency, and severity of disease. Am J Gastroenterol 96 (2001) 2957-2961
29. Struben V.M., Hespenheide E.E., and Caldwell S.H. Nonalcoholic steatohepatitis and cryptogenic cirrhosis within kindreds. Am J Med 108 (2000) 9-13
30. Brunt E.M., Janney C.G., Di Bisceglie A.M., et al. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 94 (1999) 2467-2474
31. NCEP Expert Panel. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
32. University of Florida, Executive Health Center. Medical History Questionnaire. Available: http://www.exechealth.ufl.edu/MHQ_questionnaire/EHC-MHQ.pdf. Accessed February 15, 2005.
33. Mehta C., and Patel N. STATXACT 6.0. Cytel software (2004) Cambridge, MA:
34. Palaniappan L., Carnethon M.R., Wang Y., et al. Predictors of the incident metabolic syndrome in adults. The Insulin Resistance Atherosclerosis Study. Diabetes Care 27 (2004) 788-793
35. Hitman G.A., and Sudagani J. Searching for genes in diabetes and the metabolic syndrome. Int J Clin Pract Suppl 143 (2004) 3-8
36. Bugianesi E., McCullough A.J., and Marchesini G. Insulin resistance: a metabolic pathway to chronic liver disease. Hepatology 42 (2005) 987-1000
37. Zhang J., Liu Y., Shi J., et al. Side-stream cigarette smoke induces dose-response in systemic inflammatory cytokine production and oxidative stress. Exp Biol Med 227 (2002) 823-829
38. Csiszar A., Pacher P., Kaley G., et al. Role of oxidative and nitrosative stress, longevity genes and poly (ADP-ribose) polymerase in cardiovascular dysfunction associated with aging. Curr Vasc Pharmacol 3 (2005) 285-291
39. Stevens M.J. Oxidative-nitrosative stress as a contributing factor to cardiovascular disease in subjects with diabetes. Curr Vasc Pharmacol 3 (2005) 253-266
40. Wang C.S., Wang S.T., Chang T.T., et al. Smoking and alanine aminotransferase levels in hepatitis C virus infection: implications for prevention of hepatitis C virus progression. Arch Intern Med 162 (2002) 811-815
41. Gao D., Wei C., Chen L., et al. Oxidative DNA damage and DNA repair enzyme expression are inversely related in murine models of fatty liver disease. Am J Physiol Gastrointest Liver Physiol 287 (2004) G1070-G1077
42. Rashid A., Wu T.-C., Huang C.C., et al. Mitochondrial proteins that regulate apoptosis and necrosis are induced in mouse fatty liver. Hepatology 29 (1999) 1131-1138
43. Tilg H., and Diehl A.M. Cytokines in alcoholic and nonalcoholic steatohepatitis. N Engl J Med 343 (2000) 1467-1476
44. Diehl A.M. Hepatic complications of obesity. Gastroenterol Clin North Am 34 (2005) 45-61
45. Turner R.T. Skeletal response to alcohol. Alcohol Clin Exp Res 24 (2000) 1693-1701
46. Hodgson S.F. Corticosteroid-induced osteoporosis. Endocrinol Metab Clin North Am 19 (1990) 95-111
47. Vigano A., and Mora S. Adverse effects of antiretroviral therapy: focus on bone density. Expert Opin Drug Saf 3 (2004) 199-208
48. Herman J.S., and Easterbrook P.J. The metabolic toxicities of antiretroviral therapy. Int J STD AIDS 12 (2001) 555-562
49. Borissova A.M., Tankova T., Kirilov G., et al. The effect of vitamin D3 on insulin secretion and peripheral insulin sensitivity in type 2 diabetic patients. Int J Clin Pract 57 (2003) 258-261
50. Mak R.H. Amelioration of hypertension and insulin resistance by 1,25-dihydroxycholecalciferol in hemodialysis patients. Pediatr Nephrol 6 (1992) 345-348
51. Attili A.F., Capocaccia R., Carulli N., et al. Factors associated with gallstone disease in the MICOL experience. Multicenter Italian Study on Epidemiology of Cholelithiasis. Hepatology 26 (1997) 809-818
52. Pacchioni M., Nicoletti C., Caminiti M., et al. Association of obesity and type II diabetes mellitus as a risk factor for gallstones. Dig Dis Sci 45 (2000) 2002-2006
53. Haffner S.M., Diehl A.K., Mitchell B.D., et al. Increased prevalence of clinical gallbladder disease in subjects with non-insulin-dependent diabetes mellitus. Am J Epidemiol 132 (1990) 327-335
54. Lin Y.C., Lo H.M., and Chen J.D. Sonographic fatty liver, overweight and ischemic heart disease. World J Gastroenterol 11 (2005) 4838-4842
55. Diehl A.M. Tumor necrosis factor and its potential role in insulin resistance and nonalcoholic fatty liver disease. Clin Liver Dis 8 (2004) 619-638
56. Goldring S.R. Pathogenesis of bone and cartilage destruction in rheumatoid arthritis. Rheumatology (Oxford) 42 Suppl 2 (2003) 11-16
57. Fromenty B., Robin M.A., Igoudjil A., et al. The ins and outs of mitochondrial dysfunction in NASH. Diabetes Metab 30 (2004) 121-138
58. Pessayre D., Fromenty B., and Mansouri A. Mitochondrial injury in steatohepatitis. Eur J Gastroenterol Hepatol 16 (2004) 1095-1105
59. Lenaz G. Role of mitochondria in oxidative stress and ageing. Biochim Biophys Acta 1366 (1998) 53-67
60. Ueki K., Kadowaki T., and Kahn C.R. Role of suppressors of cytokine signaling SOCS-1 and SOCS-3 in hepatic steatosis and the metabolic syndrome. Hepatol Res 33 (2005) 185-192
61. Ueki K., Kondo T., Tseng Y.H., et al. Central role of suppressors of cytokine signaling proteins in hepatic steatosis, insulin resistance, and the metabolic syndrome in the mouse. Proc Natl Acad Sci U S A 101 (2004) 10422-10427